Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma

Publisher： Karger

E-ISSN： 1423-0232|88|6|332-336

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.6, 2015-0, pp. : 332-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

By  

Oncology, Vol. 83, Iss. 5, 2012-09 ,pp. : 300-304

Karger

Access to resources Recommend Favorite

Distribution of High Chromogranin A Serum Levels in Patients with Nonmetastatic and Metastatic Prostate Adenocarcinoma

By  

Urologia Internationalis, Vol. 82, Iss. 2, 2009-03 ,pp. : 147-151

Karger

Access to resources Recommend Favorite

Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications

By  

Oncology, Vol. 89, Iss. 2, 2015-03 ,pp. : 65-69

Karger

Access to resources Recommend Favorite

Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance

By  

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 204-207

Karger

Access to resources Recommend Favorite

Intractable Facial Pain and Numb Chin due to Metastatic Esophageal Adenocarcinoma

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-11 ,pp. : 828-832

Karger

Access to resources Recommend Favorite